3M Innovations in Biopharmaceutical Purification
  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit





Our apologies...

An error has occurred while submitting. Please try again later...

Thank you!

Please click below to access whitepaper
Frost & Sullivan: Commercialisation Strategies in Global Biosimilars Industry

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit





Our apologies...

An error has occurred while submitting. Please try again later...

Thank you. Your form was submitted successfully

Please click below to access whitepaper
Frost & Sullivan: Perspective on Continuous Processing: Trends, Drivers and Strategies

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit





Our apologies...

An error has occurred while submitting. Please try again later...

Thank you. Your form was submitted successfully

Please click below to access whitepaper
Frost & Sullivan: Cell Therapy Biomanufacturing: Trends and Perspectives

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorised third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit





Our apologies...

An error has occurred while submitting. Please try again later...

Thank you! Your form was submitted successfully.

Please click below to access whitepaper
Frost & Sullivan: Enabling Novel Bioprocessing Technologies Using the Interface of Materials Science Biotechnology.

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorised third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit





Our apologies.

An error has occurred while submitting. Please try again later.

Thank you!

Your form was submitted successfully.

Please click below to access whitepaper
Frost & Sullivan: Transition to Next Gen Downstream Processing to Capitalise on Growth Opportunities in High-Value Low-Volume Biologics

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorised third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit




 

Our apologies.

An error has occurred while submitting. Please try again later.

Thank you!

Your form was submitted successfully.

Please click below to access whitepaper
Frost & Sullivan: Perspective on Next Generation Harvest Techniques

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorised third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit

  •  


Our apologies.

An error has occurred while submitting. Please try again later.

Thank you!

Your form was submitted successfully.

Please click below to access whitepaper
Frost & Sullivan: Key Trends Reshaping The Future of Bio-pharmaceutical Harvest and Clarification

  • All fields are required unless indicated optional


  •  
  • 3M takes your privacy seriously. 3M and its authorised third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit

Our apologies...

An error has occurred while submitting. Please try again later...

Thank you!

Your form was submitted successfully

Biopharmaceutical Innovation. Pure and Simple.

We understand there’s tremendous pressure to increase speed to clinicals and lower manufacturing costs. Like you, we’re scientists and engineers devoted to increasing the number and availability of life-saving pharmaceuticals. We’ll work with you to optimise your processes, applying our biopharma experience, material science, and proprietary technologies to help you develop highly effective purification solutions.


Biopharmaceutical Applications

  • At 3M, we're advancing the recombinant protein industry by building better, more efficient biopharmaceutical manufacturing processes, developing solutions that allow process compression, and enhanced drug recovery that leads to improved process economics.

  • 3M’s innovative solutions are designed to help develop the manufacturing process for virus-like particles. These remove impurity in harvest & clarification which help maximise downstream purity.

  • Servicing the plasma fractionation industry for over 30 years, 3M offers a range of products from depth filters, chromatography products, and membrane products, all of which are supported by our validation services offerings.

  • A wide range of adsorptive depth filters and membrane products for application in the chemical-pharmaceutical industry are available to suit your needs. These products may be used for a range of applications including catalyst removal and recovery, color removal, particulate filtration, and fill-finish.


Explore Product Solutions


Ready to streamline your biopharmaceutical manufacturing process?

Get in touch with a 3M Expert for tailored recommendations to transform your filtration processes and resolve challenges. Experience it for yourself with a demonstration and trial data.


Industry News

Discover insights from industry leaders on the latest trends in bioprocessing. Learn about innovations for optimisation of continuous manufacturing, changes in manufacturing landscapes from biosimilars, and new emerging markets such as cell and gene therapies.

  • Thumbnail of Key Trends Reshaping the Future of Bio-pharmaceutical Harvest & Clarification Paper
    Frost & Sullivan: Key Trends Reshaping The Future of Bio-pharmaceutical Harvest and Clarification
  • Thumbnail of A Frost & Sullivan Perspective on Next Generation Harvest Techniques Paper
    Frost & Sullivan: Perspective on Next Generation Harvest Techniques
  • Thumbnail of Transition to Next Gen Downstream Processing to Capitalise on Growth Opportunities in High-Value Low-Volume Biologics Paper
    Frost & Sullivan: Transition to Next Gen Downstream Processing to Capitalise on Growth Opportunities in High-Value Low-Volume Biologics
  • Thumbnail of Anion-Exchange Chromatographic Clarification: Bringing Simplification, Robustness, and Savings to MAb Purification Paper
    BioProcess Int'l: Anion-Exchange Chromatographic Clarification: Bringing Simplification, Robustness, and Savings to MAb Purification
  • Enabling Novel Bioprocessing Technologies PDF
    Frost & Sullivan: Enabling Novel Bioprocessing Technologies Using the Interface of Materials Science Biotechnology
  • Perspective on Continuous Processing PDF
    Frost & Sullivan: Perspective on Continuous Processing: Trends, Drivers and Strategies
  • Cell Therapy Biomanufacturing PDF
    Frost & Sullivan: Cell Therapy Biomanufacturing: Trends and Perspectives
  • Thumbnail of A Frost & Sullivan Perspective on Commercialisation Strategies in Global Biosimilars Industry Paper
    Frost & Sullivan: Commercialisation Strategies in Global Biosimilars Industry


Industry Awards

  • Image of 2017 Frost & Sullivan Global Biologics Product Leadership Award
    3M™ Emphaze™ AEX Hybrid Purifier recognised as global product leader

    2017 Frost & Sullivan Global Biologics Product Leadership Award. With its next generation technology product, the 3M™ Emphaze™ AEX Hybrid Purifier, 3M demonstrates leadership in meeting specific customer needs.

  • Image of 2018 Minnesota Tekne Biotech/Pharmaceutical Award
    3M™ Emphaze™ AEX Hybrid Purifier recognised at MN Tekne Award

    2018 Minnesota Tekne Biotech/Pharmaceutical Award. MN Tekne Awards celebrate innovation and pioneering efforts in biotechnology or pharmaceuticals to provide game-changing advancement in the healthcare field.